Coverage here follows COVID-19 as an ongoing health subject — variant emergence and spread, vaccine and booster recommendation updates, long COVID research findings, pandemic preparedness policy and the unwinding of measures and mandates that governments and institutions put in place during the acute phase. Reporting spans the clinical and the policy dimensions.
A study of 173 countries found high-income nations captured the largest economic gains from early vaccine access.
Live Poll
Should your government keep funding costly vaccine research during future global health emergencies?
November 5, 2026
AI-Designed Vaccine Blocks Wide Range of Bird Flu VariantsUniversity of Cambridge researchers report a vaccine that fully protected mice and ferrets against multiple avian influenza variants.
November 5, 2026
Covid-19 Vaccines Return Trillions, Study FindsReanalysis estimates first-year global returns of $6.43 trillion to $64.3 trillion on $79.4 billion invested in vaccine development.
November 5, 2026
Study Maps Hantavirus Receptor Binding StructureResearchers have revealed how the hantavirus spike binds its cell-surface receptor PCDH1, opening a path toward antiviral design.
November 4, 2026
Pfizer Advances Lyme Vaccine Regulatory FilingsPfizer discussed regulatory plans for its Valneva-partnered Lyme disease vaccine on its third-quarter earnings call.
November 4, 2026
Switzerland Waives Medical Bills for Injured ItaliansThe Swiss government will not seek reimbursement for treatment of Italians hurt in the Crans-Montana fire, totaling about 1.5 million francs.
November 4, 2026
EU Makes Sanofi Flu Vaccine Commitments BindingEuropean Commission ensures Sanofi stops disparaging rival flu vaccine Fluad in Germany and France through March 2030.
November 2, 2026
Indonesia Backs Higher Mandatory WHO ContributionsIndonesia's health minister urged countries to raise their mandatory payments to the World Health Organization after the United States withdrew.
November 2, 2026
WHO Says Hepatitis Elimination Progress Is Too SlowViral hepatitis B and C caused 1.34 million deaths in 2024, the World Health Organization reports.
October 31, 2026
Independent Panel Criticizes Global Pandemic NeglectA new report highlights critical funding gaps and systemic failures in response to the ongoing mpox health crisis.
October 30, 2026
Canada and EU Boost Medical Emergency CooperationThe two partners will collaborate to ensure medical countermeasures are available to address emerging health threats.
Coverage takes in variant surveillance data and its public health implications, vaccine and booster recommendation changes and the evidence behind them, long COVID symptom and mechanism research, preparedness policy updates and the policy reversals that have continued as governments and institutions recalibrate the response to an endemic rather than pandemic phase. Long COVID has emerged as a sustained research and clinical subject in its own right, with studies on mechanism, prevalence and treatment generating a coverage track that reaches patients and clinicians independently of the variant and vaccine news cycle. Preparedness policy — how governments and health systems maintain readiness for future surges or novel pathogens — has become a more prominent subject in COVID coverage as the acute emergency has receded and the institutional lessons of the pandemic response are being assessed and codified. Policy reversals and mandate expirations generate accountability coverage that tests whether the decisions being unwound were proportionate to the conditions that justified them and what the data shows about their effects.
